new-email-outline

Federal Circuit Severely Limits Patents Eligible for CBM Review

November, 22nd, 2016

By Michael J. Kosma, Michael A. Lavine On November 21, the United States Court of Appeals for the Federal Circuit held that the United States Patent and Trademark Office (“USPTO”) had improperly expanded the definition [Read More…]

WHIPgroup Welcomes Chelsea Russell

November, 16th, 2016

Chelsea A. Russell joins Whitmyer IP Group as an associate today. Ms. Russell graduated from the University of Connecticut School of Law in 2016 and has experience assisting small businesses and entrepreneurs with their trademark [Read More…]

WHIPgroup Obtains Allowance with P3 Program

November, 15th, 2016

WHIPgroup succeeded in using the Post-Prosecution Pilot (P3) Program to obtain allowance of an application directed to a module arrangement for power semiconductor devices. In response to a final office action rejecting the claims as [Read More…]

WHIPgroup Overcomes All Prior Art Rejections using P3 Program

November, 14th, 2016

WHIPgroup attorneys obtain favorable decision using the Post-Prosecution Pilot (P3) Program for a case directed to a dc supply unit for a power provision unit. After receiving a final rejection, WHIPgroup presented arguments to a [Read More…]

Continued P3 Success

November, 14th, 2016

WHIPgroup attorneys were successful in reopening prosecution for a patent application directed to voice control of medical devices. The application received a Final Office Action rejecting the claims as anticipated by two references. WHIPgroup attorneys [Read More…]

Another Win Using P3 Program

November, 14th, 2016

WHIPgroup attorneys obtained allowance of a patent application directed to a medical manipulation device. The patent application had received a final Office Action in which the claims were rejected as allegedly being anticipated by the [Read More…]

WHIPgroup Files Patent Infringement Lawsuit

November, 11th, 2016

WHIPgroup attorneys have filed a patent infringement lawsuit on behalf of WHIPgroup client RegenLab USA LLC. RegenLab is a leading manufacturer and distributor of medical and pharmaceutical products under the world-famous REGENLAB® brand. The complaint [Read More…]

P3 Program Successfully Used to Advance Prosecution

November, 10th, 2016

WHIPgroup was successful in using the Post-Prosecution Pilot (P3) Program to advance prosecution of an application for a medical manipulator system having a controller that limits use of a medical instrument when a usage count [Read More…]

Another Case Allowed Using P3 Program

November, 4th, 2016

WHIPgroup attorneys obtained allowance of an application directed to a control system for a melting and refining process. The application had received a Final Office Action that rejected the claims as obvious over a patent [Read More…]

© Copyright 2024 Whitmyer IP Group